L
Luís Monteiro
Researcher at Group Health Cooperative
Publications - 77
Citations - 1449
Luís Monteiro is an academic researcher from Group Health Cooperative. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 18, co-authored 68 publications receiving 941 citations.
Papers
More filters
Journal ArticleDOI
Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
Saman Warnakulasuriya,Omar Kujan,José Manuel Aguirre-Urizar,Jose V. Bagan,Miguel Ángel González-Moles,Alexander Ross Kerr,Giovanni Lodi,Fernanda Weber Mello,Luís Monteiro,Graham R. Ogden,Philip Sloan,Newell W. Johnson,Newell W. Johnson +12 more
TL;DR: It is recommended the establishment of a global research consortium to further study the natural history of OPMDs based on the classification and nomenclature proposed here, and link them to evidence-based interventions, to facilitate the prevention and management of lip and oral cavity cancer.
Journal ArticleDOI
Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients.
TL;DR: It is established that epilepsy due to NCC is a heterogeneous syndrome concerning age and mode of onset, seizure type, duration of epilepsy and pattern of evolution probably related with different pathogenic mechanisms.
Journal ArticleDOI
High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Inês M. B. Moura,Maria de Lurdes Delgado,Patrícia M. A. Silva,Carlos Lopes,José Barbas do Amaral,Luís Monteiro,Hassan Bousbaa +6 more
TL;DR: High CDC20 expression is associated with poor prognosis in OSCC and may be used to identify high-risk OSCC patients and may serve as a therapeutic target.
Journal ArticleDOI
Reducing Potentially Inappropriate Prescriptions for Older Patients Using Computerized Decision Support Tools: Systematic Review.
Luís Monteiro,Tiago Maricoto,Isabel S Solha,Inês Ribeiro-Vaz,Carlos Martins,Matilde Monteiro-Soares +5 more
TL;DR: More randomized controlled trials assessing the impact of computerized decision support tools that could be used both in primary and secondary health care are needed to evaluate the use of medication targets defined by the Beers or STOPP criteria.
Journal ArticleDOI
The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Ana Martins da Silva,Clara Pereira,Andreia Bettencourt,Cláudia Carvalho,Cláudia Carvalho,Ana Rita Couto,Maria Isabel Leite,Monica Marta,Marta Freijo,Paulo Costa,Paulo Costa,Denisa Mendonça,Luís Monteiro,Jácome Bruges Armas,Berta Martins,Berta Martins +15 more
TL;DR: In this population of Portuguese MS patients, the HLA-DRB1*15 allele is established as a genetic marker for susceptibility to MS and is also associated with a better outcome.